The Missile Defense Agency has selected Raytheon Missiles & Defense to continue to develop a first-of-its-kind counter-hypersonic missile, the Glide Phase Interceptor.
GPI is designed to intercept hypersonic weapons in the glide phase of flight, providing the U.S. and allies with an additional layer of defense against regional hypersonic missile threats.
This firm fixed price Other Transaction Agreement modification, valued at $41 million, increases the total value to $62 million and allows Raytheon Missiles & Defense to continue maturing its GPI design using advanced materials and technology required to intercept a hypersonic threat.
This phase will also finalize systems requirements and support accelerated development timelines.
“Our GPI is built on proven missile defense technology as its foundation,” said Tay Fitzgerald, president of Strategic Missile Defense at Raytheon Missiles & Defense.
“By using digital engineering and leveraging high technology readiness level components and subsystems already in use across Standard Missile and hypersonic programs, we can quickly advance the creation of this new interceptor.”
Raytheon Missiles & Defense is leveraging mature technologies from across the current portfolio to create efficiencies, reduce qualification time and demonstrate the GPI capability as quickly as possible.
If you would like to join our community and read more articles like this then please click here.
Missile Defense Agency Raytheon Missiles & Defense
Post written by: Matt Brown
.
RELATED ARTICLES
December 15, 2023
Land - Northrop Grumman supports end-to-end missile defence demo
Northrop Grumman has supported Missile Defense Agency’s (MDA) test of the Ground-Based Midcourse Defense (GMD) system. The FTG-12 test used a
September 27, 2022
Air - Raytheon and Northrop Grumman to deliver first hypersonic air-breathing missile
Raytheon Missiles & Defense, in partnership with Northrop Grumman, has been selected to develop the Hypersonic Attack Cruise Missile for
